Skip to content
Research/Supplements/Bacopa Monnieri

Bacopa Monnieri

Adaptogenic herb for memory and stress support. Supplement.

Intelligence Profile

Clinical Applications

Bacopa monnieri is primarily investigated clinically for cognitive enhancement and neuroprotection, with research focusing on several key therapeutic areas:

Cognitive Function and Memory Enhancement

The most established clinical application of Bacopa monnieri is for cognitive support, particularly memory enhancement. Clinical trials have examined its effects on various cognitive parameters, including working memory, attention, and executive function. One notable study (NCT02462642) specifically investigated Bacopa extract's effects on both cognition and anxiety, suggesting dual therapeutic potential.

A recent clinical study examined the sequential administration of traditional Ayurvedic formulations including Brahmi (Bacopa monnieri) in patients with mild cognitive impairment, measuring changes in Montreal Cognitive Assessment (MoCA) scores. This exploratory single-arm study provides preliminary evidence for cognitive benefits in this population.

Neurodegenerative Conditions

Emerging research suggests potential applications in neurodegenerative diseases, particularly Alzheimer's disease. A comprehensive review of medicinal plants for Alzheimer's disease included Bacopa monnieri among compounds showing translational potential, though the evidence base remains primarily preclinical.

Preclinical studies have demonstrated that Bacopa-enriched formulations can enhance memory and synaptic plasticity in animal models of vascular dementia, suggesting potential therapeutic applications for dementia-related conditions.

Brain Function and Neuroprotection

Clinical neuroimaging studies have investigated Bacopa's effects on brain hemodynamics. One completed fMRI study (NCT02345187) examined hemodynamic changes in the brain following Bacopa monnieri supplementation, providing insights into its neurological mechanisms of action.

Research into brain-derived neurotrophic factor (BDNF) levels after Bacopa supplementation (NCT03974399) suggests the herb may influence neuroplasticity markers, though specific clinical outcomes from this study are not detailed in the available evidence.

Other Potential Applications

Limited research has explored Bacopa monnieri for conditions beyond cognitive enhancement, including potential applications in managing alopecia, though this remains largely theoretical based on mechanistic studies rather than robust clinical evidence.

Evidence Limitations

While several clinical trials have been completed investigating Bacopa monnieri, the available evidence summaries do not provide detailed results or effect sizes from these studies. Most trials appear to be exploratory in nature, and the evidence base would benefit from larger, well-controlled studies with standardized outcome measures.

Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before using Bacopa monnieri for any medical condition.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.